Last reviewed · How we verify
NCT06617130
The Efficacy of Amino Acid Supplementation in Treating Environmental Enteric Dysfunction Among Children At Risk of Malnutrition
NA trial testing Corn soy bean blended flour porridge plus indispensable amino acid in Amino Acid, Stunting, Environmental Enteric Dysfunction in 66 participants. Not yet recruiting.
1 August 2026
Quick facts
| Lead sponsor | Kamuzu University of Health Sciences |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 66 |
| Start date | 1 November 2024 |
| Primary completion | 1 August 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across Malawi |
Drugs / interventions tested
- Corn soy bean blended flour porridge plus indispensable amino acid
Conditions studied
- Amino Acid, Stunting, Environmental Enteric Dysfunction — all drugs for Amino Acid, Stunting, Environmental Enteric Dysfunction →
Sponsor
Kamuzu University of Health Sciences
Who can join
Adults 18 Months to 36 Months, any sex, with Amino Acid, Stunting, Environmental Enteric Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomised controlled open label clinical trial to determine whether addition of indispensable amino acids (IAA) to standard complementary food will reduce occurrence of Environmental Enteric Dysfunction (EED) compared with provision of standard complementary food without IAA in healthy Malawian children aged 18-36 months with or without stunting.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of indispensable amino acid supplementation on gut function in children at high risk of environmental enteropathy: protocol for an international coordinated group of randomised controlled trials.
Lee GO, Owino V, Baquiran AFP, Pasanna RM, et al · · 2026 · PMID 42031499 · DOI 10.1136/bmjopen-2025-105456
Verify or expand the search:
- PubMed search for NCT06617130
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Kamuzu University of Health Sciences trials
Trials by the same sponsor.
- NCT06424002 — The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children · Phase 4 · not yet recruiting
- NCT06900361 — Use of Mobile Phone Application for Asthma Sele Management · completed
- NCT04625452 — Feasibility and Efficacy of Brief Behavior Change Counseling on Lifestyle in Hypertensive and Diabetics Participants · NA · unknown
- NCT03376217 — Assessing the Effectiveness of Community Delivery of Intermittent Preventive Treatment in Pregnancy (IPTp) in Malawi · NA · completed
- NCT03009526 — Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06617130 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kamuzu University of Health Sciences
- Last refreshed: 27 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06617130.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing